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ABSTRACT
The pharmacokinetics of cefquinome (2 mg/kg) were studied following intramuscular administration of 
cefquinome alone, and co-administered with tolfenamic acid (2 mg/kg) in sheep. The plasma concentration of 
cefquinome was detected by High Performance Liquid Chromatography. Following a single dose intramuscular 
administration of cefquinome alone, the peak plasma concentration (C
max
) was 4.36 ± 0.10 μg/mL obtained 
at 0.75 h. The absorption half-life (t
1/2Kα
), volume of distribution (Vd
area





) of cefquinome were 0.61 ± 0.10 h,2.07 ± 0.36 L/kg, 0.12 ± 0.01 L/h/kg and 12.29 
± 2.62 h, respectively. Following intramuscular co-administration of tolfenamic acid, no signiﬁ cant changes 
were observed in most of the pharmacokinetic parameters of cefquinome, except C
max 
and the absorption rate 
constant (K
a




 was signiﬁ cantly reduced compared to cefquinome alone 
treatment of sheep. Cefquinome pharmacokinetic data (2 mg/kg) generated from the present study suggest that 
cefquinome may be administered with tolfenamic acid to treat bacterial infection with inﬂ ammatory conditions 
in sheep.
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Introduction 
Non-steroidal anti-inﬂ ammatory drugs (NSAIDs) are widely prescribed with 
antibacterial agents in multiple drug prescriptions. Cefquinome is the ﬁ rst animal 
dedicated, fourth generation cephalosporin antibiotic having a broad spectrum of activity. 
The zwitterionic property of cefquinome facilitates rapid penetration across the biological 
membranes, including the porins of the bacterial cell wall, enhancing bioavailability 
and improving the spectrum of antimicrobial activity, compared with second and third 
*Corresponding author:
Dr. K. A. Sadariya, M.V.Sc., Ph.D., Assistant Professor, Department of Pharmacology and Toxicology, College of Veterinary 
Science and Animal Husbandry, Anand Agricultural University, Anand-388001, Gujarat, India, Phone: +91 9427 180817; 
Phone & Fax: +91 2692 261486; E-mail: dr_kasadariya@yahoo.co.in
284 Vet. arhiv 85 (3), 283-292, 2015
M. P. Rana et al.: Effect of tolfenamic acid on the pharmacokinetics of cefquinome in sheep
generations cephalosporins (SADER and JONES, 1993; SHPIGEL and SCHMID, 1997; 
GUERIN-FAUBLEE et al., 2003; THOMAS et al., 2002). Tolfenamic acid (TA) is an NSAID 
of the fenamate group with excellent anti-inﬂ ammatory, analgesic, anti-pyretic activities, 
and anti-endotoxaemic properties (REJHOLEC et al., 1979). It inhibits the biosynthesis of 
prostaglandins and also has an inhibitory action on prostaglandin receptors. Moreover, 
it also produces inhibition of cyclooxygenase and lipoxygenase (LINDEN et al., 1976; 
PROUDMAN and McMILLAN, 1991; KANKAANRANTA et al., 1991). NSAIDs are 
frequently recommended as an adjunct therapy with antibacterial, to treat various bacterial 
infections accompanied by many inﬂ ammatory conditions in animals. A higher volume 
of distribution of tolfenamic acid was found in the marboﬂ oxacin-treated calves (SIDHU 
et al., 2005). Co-administration of several drugs often results in unpredictable therapeutic 
outcome. Hence, this study was conducted to recommend the clinical use of cefquinome 
in combination with tolfenamic acid in the treatment of susceptible bacterial diseases 
affecting sheep. Cefquinome is stable against chromosomally and plasmid-encoded 
lactamases produced by the majority of clinically important bacteria (LIMBERT et al., 
1991). Pharmacokinetic studies of cefquinome have been conducted in buffalo calves 
(DINAKARAN et al., 2013), goats (DUMKA et al., 2013), chickens (XIE et al., 2013), piglets 
(SONG et al., 2013), sheep (UNEY et al., 2011; TOHAMY et al., 2011), ducks (YUAN et al., 
2011), rabbit (HWANG et al., 2011), horses (WINTHER et al., 2011), camels (AL-TAHER, 
2010) and pigs (YANG et al., 2009).
However, there is no information available on the inﬂ uence of the co-administration of 
tolfenamic acid on the pharmacokinetics of cefquinome in animals. So, the present study 
was conducted to investigate the inﬂ uence of tolfenamic acid on the pharmacokinetics of 
cefquinome in sheep. 
Materials and methods
Drug and chemicals. Cefquinome technical grade pure powder was procured from 
Sigma-Aldrich, India; Cefquinome suspension (25 mg/50 mL; Cobactan® 2.5 %, Intervet 
India Pvt. Ltd., Pune, India) and tolfenamic acid injections (40 mg/mL; Maxxtol®, Intas 
Pharmaceutical Ltd. Ahmedabad, India) were purchased on the market. Acetonitrile, 
methanol, triﬂ uroacetic acid and perchloric acid (about 70 %) (Analytical grade) and 
water of HPLC grade were purchased from Merck Limited, Mumbai, India.
Experimental animals. The experiment was conducted on six healthy adult (2-3 
years of age) Patanwadi sheep, weighing 28-32 kg. Each sheep was housed in a separate 
pen and provided ad libitum water and standard ration. The sheep were kept under 
constant observation for two weeks before the commencement of the experiment and 
all necessary managerial procedures were adopted to keep the animals free from stress. 
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The experimental protocol was approved by the Institutional Animal Ethics Committee 
(IAEC No. 2012/VPT/135).
Experimental design. The study was carried out in cross-over design, with a minimum 
of 15 days of washout period. All six animals were randomly allocated to receive a single 
intramuscular injection of cefquinome (2 mg/kg, body mass) alone, or co-administered 
with intramuscular administration of tolfenamic acid (2 mg/kg, body mass). Both the 
drugs were administered one by one in the co-administered group within a few seconds. 
A washout period of 2 weeks was observed between treatments. Intramuscular injection 
was given into the deep gluteal muscles, using a 20 G ×25 mm needle. Blood samples (2 
mL) were collected in sterile heparinized vials at 0 minute (before drug administration) 
5, 10, 15, 30 and 45 minutes and at 1, 2, 4, 8, 12, 18, 24 and 36 hours after intramuscular 
administration. The sheep were monitored for any adverse reactions throughout the 
entire study period. Plasma was separated soon after collection by centrifugation at 3000 
rpm for 10 minutes at 10 oC (Eppendorf 5804 R, Germany). Separated plasma samples 
were transferred to labeled cryovials and stored at -35 oC until assayed for cefquinome 
concentration, using the High Performance Liquid Chromatography (HPLC) procedure 
within 24 to 36 h.
Cefquinome assay
Instrumentation. Plasma cefquinome concentrations were quantiﬁ ed using reverse-
phase High Performance Liquid Chromatography (HPLC), according to the method 
described by UNEY et al. (2011) with minor modiﬁ cations. The HPLC system of Lab 
alliance (Scientiﬁ c Systems, Inc., Lab Alliance, Pennsylvania, USA), comprising 
a quaternary gradient delivery pump (model AIS 2000) connected to an Autosampler 
(model Sykam S 5200, Sykam GmbH, Gewerbering, Eresing, Germany) and UV detector 
(model 500) was used for the assay. 





 % A 
(0.1 % Triﬂ uoroacetic acid in water)
 % B
(Acetonitrile)
Initial 1.5 90 10
1 1.5 10 90
4 1.5 10 90
5 1.5 90 10
Chromatographic conditions. The mobile phase consisted of water containing 0.1 % 
triﬂ uoroacetic acid as mobile phase A, and acetonitrile as mobile phase B in the gradient 
ﬂ ow, as shown in Table 1. Chromatographic separation was performed using a reverse 
phase C18 column (PARTISIL 5 ODS-3 RAC-II; 4.6 ×100 mm ID, Whatman, Kent, 
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UK) at room temperature. HPLC data integration was performed using Clarity software 
(Version 2.4.0.190, Dataapex, Central Europe). The mobile phase was ﬁ ltered through a 
0.45 μm size ﬁ lter (Ultipor N66 Nylone 6,6 membrane, PALL Pharmalab ﬁ ltration Pvt., 
Ltd., Mumbai, India) and degassed by ultra-sonication. The mobile phase was pumped 
into the column at a ﬂ ow rate of 1.5 mL/min at ambient temperature. The efﬂ uent was 
monitored at 270 nm wavelength. 
Calibration curve. A calibration curve was prepared daily for drug concentrations 
ranging from 0.1 to 10 μg/mL, with mean correlation coefﬁ cient (r2) >0.999. The limits 
of detection and limits of quantiﬁ cation were determined to be 0.05 and 0.1 μg/mL, 
respectively.
Sample extraction. Two hundred microliters (0.2 mL) of plasma were deproteinized 
by addition of methanol (400 μL) and vortexed for one minute. The mixture was vortexed 
for 1 minute and centrifuged at 10000 rpm for 5 minutes at 10 oC (Eppendorf 5804 R, 
Germany). The supernatant was decanted into a clean sterile micro centrifuge tube, and 
20 μL supernatant was injected into the loop injector using the autosampler.
Validation of the assay method. The assay was sensitive and reproducible, and 
linearity was observed from 0.1 to 10 μg/mL (r2 = 0.999). Plasma samples (n = 5) with the 
ﬁ nal concentrations of 0.25, 1, 2.5 and 5 μg/mL for cefquinome were extracted according 
to the procedure mentioned above. To fulﬁ ll the requirement of partial validation of the 
modiﬁ ed method, intra-day and inter-day precision and accuracy were evaluated. The 
intra-day assay precision and accuracy were estimated by analyzing six replicates at four 
different QC levels, i.e. 0.25, 1, 2.5 and 5 μg/mL. The assay values on both occasions 
(intra- and inter-day) were found to be within the accepted variable limits. Precision and 
accuracy of the assay, in conjunction with the linearity, indicates good accuracy of the 
assay with a coefﬁ cient of variance (C.V.) less than 9.13 %.
Pharmacokinetics analysis. The various pharmacokinetic parameters were calculated 
from plasma concentrations of cefquinome using software PK solution (version 2.0, 
summit research services, USA).
Statistical analysis. All the data are presented as mean ± S.E. Plasma concentrations 
and pharmacokinetic parameters were compared by the student’s t-test, using SPSS 
software (version 12.0.1). Statistical signiﬁ cance was set at P≤0.05 and P≤0.01.
Results
No adverse effects or toxic manifestations were observed during the experimental 
period with regards to intramuscular administration of cefquinome (2 mg/kg) alone or co-
administered with tolfenamic acid (2 mg/kg) in sheep. Plasma cefquinome concentrations 
at different time intervals following intramuscular injection alone and co-administered 
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intramuscularly with tolfenamic acid in sheep are presented as a semi logarithmic plot in 
Fig. 1. Non-compartmental pharmacokinetic analysis was performed using PK solution 
software, to calculate various pharmacokinetic parameters. 
Fig. 1. Semi logarithmic plot of plasma cefquinome concentration versus time following 
intramuscular administration of cefquinome (2 mg/kg) alone and in tolfenamic acid treated (2 mg/
kg) sheep. Each point represents mean ± SE of six animals.
Following intramuscular injection of cefquinome alone, the plasma concentration 
of cefquinome at 5 min was 0.49 ± 0.01 μg/mL, which gradually increased and reached 
the peak concentration (4.36 ± 0.10 μg/mL) at 45 min. On concurrent administration of 
tolfenamic acid and cefquinome, the initial plasma concentration of cefquinome at 5 min 
was 0.51 ± 0.01 μg/mL, which increased to attain the peak plasma concentration (4.73 ± 
0.05 μg/mL) at 45 min. Cefquinome was not detected in plasma samples collected after 
18 h post intramuscular administration in either treatment group. 
Following intramuscular administration of cefquinome alone, the absorption rate 
constant (K), absorption half-life (t1/2Kα), volume of distribution (Vdarea), total body 
clearance (Cl
B
) and elimination half-life (t
1/2β
) of cefquinome were 1.27 ± 0.17 h-1, 0.61 ± 
0.10 h, 2.07 ± 0.36 L/kg, 0.12 ± 0.01 L/h/kg and 12.29 ± 2.62 h, respectively, while AUC, 
AUMC and MRT were 16.65 ± 0.57 μg.h/mL, 157.05 ± 37.93 μg.h2/mL and 9.14 ± 1.83 
h. The various pharmacokinetic parameters of cefquinome (2 mg/kg) following a single 
dose intramuscular administration alone and in tolfenamic acid (2 mg/kg) treated sheep 
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Table 2. Pharmacokinetic parameters of cefquinome (2 mg/kg) following a single dose, 
intramuscular administration alone and in co-administration with tolfenamic acid (2 mg/kg) 
treated sheep (Mean ± SE, n = 6)
Pharmacokinetic
parameter Units
Mean ± SE 
Normal/Healthy Tolfenamic acid-treated 
K h
-1 1.27 ± 0.17 2.75 ± 0.17**
t½K h 0.61 ± 0.10 0.26 ± 0.01**
t½ h 12.29 ± 2.62 9.00 ± 0.51
C
max
g/mL 4.36 ± 0.10 4.73 ± 0.05*
T
max
h 0.75 ± 0.01 0.75 ± 0.01
AUC(0 - ) g.h/mL 16.65 ± 0.57 17.52 ± 0.14
AUMC g.h2/mL 157.05 ± 37.93 127.55 ± 5.24
Vd
(area)
L/kg 2.07 ± 0.36 1.48 ± 0.08
Cl
(B)
L/h/kg 0.12 ± 0.01 0.11 ± 0.01
MRT h 9.14 ± 1.83 7.27 ± 0.27
*Signiﬁ cant at P<0.05, **Signiﬁ cant at P<0.01 when compared with respective values of cefquinome alone 
(IM) and in tolfenamic acid (IM) treated sheep. K
a
: Absorption rate constant, t
1/2ka





: Maximum drug concentration, T
max
: Time of maximum observed concentration in 
serum, AUC
0-∞
: Area under the curve, AUMC: Area under ﬁ rst moment of curve, Vd
area
: Apparent volume of 
distribution, Cl
(B)
: Total body clearance, MRT: Mean residence time.
Discussion
In the present study, following intramuscular administration of cefquinome in 
tolfenamic acid-treated sheep, a signiﬁ cant decrease in absorption half-life (t
½Ka
) (0.26 ± 
0.01 h) and maximum drug concentration (4.73 ± 0.05 μg/mL) was observed, whereas all 
other pharmacokinetic parameters were not signiﬁ cantly altered as compared to healthy 
sheep. 
A signiﬁ cant increase in peak plasma concentration (C
max
) of cefquinome was 
observed in tolfenamic acid co-administrated sheep (4.73 ± 0.05 μg/mL) as compared 
to cefquinome alone treated sheep (4.36 ± 0.10 μg/mL). Similarly, several other authors 
have also reported an increase in the C
max
 of different cephalosporins following its co-
administration with anti-inﬂ ammatory drugs. The present ﬁ nding was in accordance 
with the report of an increase in C
max
 of cefepime following concurrent intramuscular 
ketoprofen administration (PATEL et al., 2012a). Likewise, a signiﬁ cant increase in the 
C
max
 of ceftizoxime following concomitant intramuscular administration of paracetamol 
was observed in cross-bred calves by SINGH et al. (2008). The ﬁ nding of the present study 
is in agreement with the signiﬁ cant increase in C
max
 of cefazolin following intramuscular 
co-administration of phenylbutazone, as reported in rabbits by CARBON et al. (1981). 
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Also BAROT (2011) reported a signiﬁ cant increase in the C
max
 of cefpirome, following co-
administration of ketoprofen in goats. In the same way, the enhanced C
max
 of cefotiam and 
ceftriaxone, following concomitant administration of diclofenac in rabbits, was observed 
by JOLY et al. (1988). In contrast to the present study, no signiﬁ cant difference in the 
C
max
 of cefepime was observed following concomitant intramuscular administration of 
ketoprofen in goats (PATEL et al., 2012b). 
In the present study, following intramuscular administration of cefquinome with 
tolfenamic acid in sheep, the major pharmacokinetics parameters were not signiﬁ cantly 
altered in comparison to sheep administered cefquinome alone. Similarly, the major 
pharmacokinetic parameters of cefmenoxime remained unaffected following concomitant 
diclofenac sodium administration in rabbits (JOLY et al., 1988) which supports the results of 
our study. No signiﬁ cant alterations were found in the major pharmacokinetic parameters 
of cefepime following its concomitant intramuscular administration with ketoprofen 
in sheep (PATEL et al., 2012a), which is in agreement with the present study. Likewise, 
the pharmacokinetic parameters of cefepime remained unaltered following concomitant 
administration with ketoprofen in goats (PATEL et al., 2012b), which is in accordance with 
our study. Similarly, BAROT (2011) also reported no noteworthy alteration in the major 
pharmacokinetics parameters of cefpirome following co-administration of ketoprofen 
in goats. Furthermore, PATIL et al. (2012) also reported no signiﬁ cant alteration in the 
pharmacokinetics of cefepime following co-administration of ketoprofen in cow calves 
which also supports our study. 
In contrast to the present study, RANJAN et al. (2009) reported signiﬁ cant alterations 
in distribution half-life (t
1/2α





following co-administration of meloxicam in sheep. A signiﬁ cant increase in the value of 
elimination half-life (t
1/2β
) of cefazolin was also reported following co-administration with 
phenylbutazone in rabbits by CARBON et al. (1981). Asigniﬁ cant increase in the AUC and 
t
1/2β 
of ceftizoxime was reported following concomitant administration with paracetamol 
in crossbred calves by SINGH et al. (2008). However, a signiﬁ cant increase in the absorption 
half-life (t
½K) of cefepime was reported following co-administration with ketoprofen in 
sheep by PATEL et al. (2012a). Reports of alterations in the pharmacokinetic parameters 
of cephalosporin when co-administered with NSAIDs may be due to differences in the 
species of animal and the chemical nature of the drugs.
The ﬁ ndings of the present study showed that no signiﬁ cant alterations in the major 
pharmacokinetic parameters of cefquinome were observed following its concomitant 
administration with tolfenamic acid in sheep. So, it may be concluded that intramuscular 
administration of tolfenamic acid (2 mg/kg) may be successfully co-administrated with 
cefquinome (2 mg/kg) for combating bacterial infections with an inﬂammatory condition 
in sheep. 
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SAŽETAK 
Istražena je farmakokinetika cefkvinoma (2 mg/kg) nakon njegove intramuskularne primjene i istodobno 
u kombinaciji s tolfenaminskom kiselinom (2 mg/kg) u ovaca. Koncentracija cefkvinoma u plazmi bila je 
određena visokotlačnom tekućinskom kromatograﬁ jom. Vršna koncentracija cefkvinoma u plazmi (C
max
) 0,75 
h nakon primjene jedne njegove doze iznosila je 4,36 ± 0,10 μg/mL. Poluživot apsorpcije cefkvinoma (t
1/2Kα
) 
iznosio je 0,61 ± 0,10 h, njegov volumen raspodjele (Vd
area
) 2,07 ± 0,36 L/kg, ukupni klirens iz organizma (Cl
B
) 
0,12 ± 0,01 L/h/kg te poluživot izlučivanja (t
1/2β
) 12,29 ± 2,62 h. Nakon istodobne intramuskularne primjene 
tolfenaminske kiseline nisu ustanovljene značajne promjene u većini farmakokinetičkih pokazatelja cefkvinoma 
osim za C
max 
i konstante stope apsorpcije (K) koji su bili značajno povećani dok je t1/2 Ka bio značajno smanjen 
u usporedbi s primjenom samog cefkvinoma. Farmakokinetički pokazatelji cefkvinoma (2 mg/kg) proizašli iz 
ovog istraživanja upućuju na zaključak da se cefkvinom može u ovaca primijeniti istodobno s tolfenaminskom 
kiselinom za liječenje bakterijskih infekcija s upalnim promjenama. 
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